Design,Synthesis and Evaluation of Orally Available Multi-Target-Directed Ligands for the Cognitive

来源 :2015年全国药物化学学术会议暨第五届中英药物化学学术会议 | 被引量 : 0次 | 上传用户:ffxcat
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Microtubules are critical elements that are involved in a wide range of cellular processes,and thus,they have become an attractive target for many anticancer drugs.[1] A novel synthesized compound,12P inhibits tubulin polymerization through binding to the colchicine-binding site of tubulin.
其他文献
肿瘤发生是一个多因素参与、多基因改变、多步骤的复杂过程。利用系统生物学网络寻找潜在靶点,设计新型靶向抗肿瘤活性化合物,是肿瘤药物的重要方向。在前期朴素贝叶斯模型构建网络研究凋亡的工作中,我们发现AMPK 处于预测的凋亡激酶的网络核心,并联同ZIPK 共同调控凋亡激酶核心通路。
More and more attention has been paid to natural flavonols,a class of natural flavonoids,which widely exist in medicinal plants,fruits and vegetables.
Berberine(Fig.1),an isoquinoline alkaloid,is the major pharmacological component of the Chinese herb Coptis chinensis(Huang-Lian,a common herb in traditional Chinese medicine).
成纤维细胞生长因子(FGF)与肿瘤的血管形成有着十分密切的关系。英国阿斯利康公司报道了一种新型FGF 受体(FGFR)高选择性抑制剂---AZD4547[1]。此外,美国礼来公司也研发出一类具有乙烯基吲唑类结构的FGFR 抑制剂LY2874455[2]。
Primary liver cancer,also known as human hepatocellular carcinoma(HCC),is the fifth most common cause of cancer mortality and its incidence is increasing worldwide.
成纤维细胞生长因子受体(FGFR)作为一种常见的酪氨酸激酶受体,具有很强的促进细胞增殖和分化的作用。以FGFR 为靶标对肿瘤进行治疗的最有效方法就是研发FGFR 抑制剂药物,尽管已有该类药物上市,但相对于其它生长因子抑制剂来说,FGFR抑制剂相对年轻。
Human hepatocellular carcinoma(HCC)is the most common primary malignancy of the liver and a major cause of cancer death.Recently a novel class of pyridazinone derivatives for anti-hepatocellular was d
Aurones have been reported to possess many bioactivities such as anticancer,anti-inflammatory and anti-Alzheimers desease(AD).Recently,aurone derivatives have been widely applied as amyloid imaging ag
会议
Flurbiprofen is being considered for the treatment of Alzheimers disease because epidemiological data indicates that non-steroidal anti-inflammatory drugs are protective against neurodegeneration.
会议
Tubulin-microtubule system,which involves crucially in the cell mitosis is an attractive target for the development of highly efficient anticancer drugs.[1] A series of cyclic iso-Combretastatin A-4(i